Grant Income	9 Months Ended
Sep. 30, 2022
Grant Income
Grant Income	(4) Grant Income In September 2019, as modified in September 2020, the Company received a Notice of Award for a $1.9 million grant from the National Institute on Aging of the National Institutes of Health (the “NIH”) to cover costs of long-term chronic toxicology studies of buntanetap in rats and dogs. The Company began the long-term chronic toxicology studies in November 2019. As of September 30, 2022 there were no remaining funds available under the grant. The Company did not recognize any grant income for the three months ended September 30, 2022 and 2021, respectively, and recognized $0 and $36,754 for the nine months ended September 30, 2022 and 2021, respectively. The Company received payments under the grant of $0 and $36,754 during the nine months ended September 30, 2022 and 2021, respectively. The Company recorded a grant income receivable of $0 as of September 30, 2022 and December 31, 2021, and had no unreimbursed, eligible costs incurred under the grant.

Grant Income

9 Months Ended

Sep. 30, 2022

(4) Grant Income

In September 2019, as modified in September 2020, the Company received a Notice of Award for a $1.9 million grant from the National Institute on Aging of the National Institutes of Health (the “NIH”) to cover costs of long-term chronic toxicology studies of buntanetap in rats and dogs. The Company began the long-term chronic toxicology studies in November 2019. As of September 30, 2022 there were no remaining funds available under the grant. The Company did not recognize any grant income for the three months ended September 30, 2022 and 2021, respectively, and recognized $0 and $36,754 for the nine months ended September 30, 2022 and 2021, respectively. The Company received payments under the grant of $0 and $36,754 during the nine months ended September 30, 2022 and 2021, respectively. The Company recorded a grant income receivable of $0 as of September 30, 2022 and December 31, 2021, and had no unreimbursed, eligible costs incurred under the grant.